MedPath
NMPA Approval

Insulin Aspart 30 Injection

国药准字S20200024

December 2, 2020

Drug Information

门冬胰岛素30注射液

注射剂

3ml:300单位

生物制品

December 2, 2020

Company Information

Applicant Company

北京市通州区漷县镇南凤西一路8号

Manufacturing Company

北京市通州区漷县镇南凤西一路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

门冬胰岛素30注射液 - NMPA 批准文号 | MedPath